partnership overview

Strength through partnerships

Intravacc collaborates with a diverse network of global partners, including universities, government institutions, biotech, and pharmaceutical companies, to strengthen our mission of advancing promising vaccine candidates through the development pipeline. We specialize in innovative vaccine concepts and provide tailored solutions to meet unique needs.

Process Development 06

Partners in vaccine concept development 

Our state-of-the-art facilities are equipped to work with various vaccine platforms, allowing us to produce customized GMP-grade pilot lots that support your phase I or II clinical trials. We are currently engaged in active partnerships with biotech and government organizations, via various collaboration models, including licensing agreements.

Meet some of our partners

Publicly funded partnerships

In conjunction with our partners, we actively participate in obtaining public funding for the development of novel vaccine concepts and clinical studies. Several projects are currently underway.

Read about our publicly funded projects

Partnership 03
Partnerships 02

Explore partnership opportunities

Intravacc offers non-exclusive partnership opportunities for several proprietary technologies, including:

  • Outer Membrane Vesicle-based vaccine technology (OMV-Vacc) 
  • Cell-Based vaccine technology (Cell-Vacc)
  • Conjugation-based vaccine technology (Con-Vacc)
  • Escherichia coli expression system technology (

Get an overview

Join us in advancing vaccine innovation and global health solutions through collaborative partnerships. Contact us to explore how we can work together.

Contact us

Contact us

You can send us an email:

Reach out to Business Development:

Or pick up the phone: 
+31 30 792 03 00

You can also just fill out the contact form on the right.

We look forward to hearing from you!


Contact form

Subscribe to our newsletter